Earning are due out in 3 weeks. Insiders always know ahead of time. Can this be a run-up to reported earnings? A small biotech with real earnings is rare. Any real increase should put us over 10 for good IMO.
This runnnnnnnupppppp has been so profound and so fast $7-$10 just cannot imagine it continues without some significant news or growth or projections or acquire etc or it can just as easily trend down BUT over $10 is a very significant mark / now can we stay maintain and continue up. Hope hope this continues!
run up due to more buyers / insiders and friends - over 10 - all good.
Have been with this small biotech almost by accident for way to long - now finally a core product with
top and bottom line growth potential along caveats of partnerships / acquisitions mucho cash / IP / down the road being acquired when we reach minimum $100M threshold for a larger biotech to be interested / no fda ups & downs and hoops.